다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Repros Therapeutics Inc. (MM) (RPRXD)
Repros Therapeutics Inc. (MM) (RPRXD) 뉴스

RPRXD

Repros Therapeutics Inc. (MM) (RPRXD)

Repros Therapeutics Inc. (MM)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:RPRXD

1

일자	시간	출처	헤드라인	심볼	기업
2010/11/11	02:27	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:RPRXD	Repros Therapeutics Inc. (MM)
2010/11/10	03:29	Business Wire	Repros® Therapeutics Reports Outcome of Type B Meeting with FDA Regarding Androxal® in the Treatment of Secondary Hypogonadism	NASDAQ:RPRXD	Repros Therapeutics Inc. (MM)
2010/11/02	01:27	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:RPRXD	Repros Therapeutics Inc. (MM)
2010/10/30	06:20	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RPRXD	Repros Therapeutics Inc. (MM)
2010/10/30	06:20	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RPRXD	Repros Therapeutics Inc. (MM)
2010/10/30	06:04	Business Wire	Repros® Has Regained Compliance with Nasdaq Continued Listing Requirements	NASDAQ:RPRXD	Repros Therapeutics Inc. (MM)
2010/10/26	02:05	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:RPRXD	Repros Therapeutics Inc. (MM)
2010/10/25	23:36	Business Wire	Repros® Therapeutics Begins Randomization of Subjects in Androxal® Type II Diabetes Phase II Trial	NASDAQ:RPRXD	Repros Therapeutics Inc. (MM)
2010/10/16	06:39	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RPRXD	Repros Therapeutics Inc. (MM)
2010/10/15	23:53	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:RPRXD	Repros Therapeutics Inc. (MM)

검색 관련기사 보기:NASDAQ:RPRXD

1

Templeton Emerging Markets

Mercialys Paris (PK)

ITUBR368 Ex:35,5

WisdomTree BioRevolution

Motion Acquisition

Imperial Petroleum

Dragonfly Energy

Vontobel Financial Produ...

Panacea Acquisition

Oaktree Specialty Lending

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관